Oxacillinase-484-Producing Enterobacterales, France, 2018-2023.

France / epidemiology beta-Lactamases / genetics Humans Anti-Bacterial Agents / pharmacology Microbial Sensitivity Tests Plasmids / genetics Enterobacteriaceae / genetics Enterobacteriaceae Infections / microbiology Escherichia coli / genetics History, 21st Century
Antimicrobial resistance E. coli ST1722 E. coli ST410 Enterobacterales Escherichia coli France OXA-484 bacteria carbapenemase epidemiology oxacillinase

Journal

Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155

Informations de publication

Date de publication:
Oct 2024
Historique:
medline: 25 9 2024
pubmed: 25 9 2024
entrez: 25 9 2024
Statut: ppublish

Résumé

We examined the emergence and characteristics of oxacillinase-484-producing Enterobacterales in France during 2012-2023. Genomic analysis identified 2 predominant sequence types in Escherichia coli: ST410 and ST1722. Plasmid analysis revealed that bla

Identifiants

DOI: 10.3201/eid3010.240814 PMID: 39320334
pubmed: 39320334
doi: 10.3201/eid3010.240814
doi:

Substances chimiques

beta-Lactamases EC 3.5.2.6
oxacillinase EC 3.5.2.6
Anti-Bacterial Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2178-2182

Auteurs

Cécile Emeraud (C)

Sandrine Bernabeu (S)

Delphine Girlich (D)

Inès Rezzoug (I)

Agnès B Jousset (AB)

Aurélien Birer (A)

Thierry Naas (T)

Rémy A Bonnin (RA)

Laurent Dortet (L)

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Régions géographiques › Europe › France › Oxacillinase-484-Producing Enterobacterales,...
questionsmedicales.fr › Enzymes et coenzymes › Enzymes › Hydrolases › Amidohydrolases › bêta-Lactamases › Oxacillinase-484-Producing Enterobacterales,...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Oxacillinase-484-Producing Enterobacterales,...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antibactériens › Oxacillinase-484-Producing Enterobacterales,...
questionsmedicales.fr › Techniques d'investigation › Évaluation préclinique de médicament › Tests de sensibilité microbienne › Oxacillinase-484-Producing Enterobacterales,...
questionsmedicales.fr › Phénomènes génétiques › Structures génétiques › Plasmides › Oxacillinase-484-Producing Enterobacterales,...
questionsmedicales.fr › Bactéries › Proteobacteria › Gammaproteobacteria › Enterobacteriaceae › Oxacillinase-484-Producing Enterobacterales,...
questionsmedicales.fr › Infection › Infections bactériennes et mycoses › Infections bactériennes › Infections bactériennes à Gram négatif › Infections à Enterobacteriaceae › Oxacillinase-484-Producing Enterobacterales,...
questionsmedicales.fr › Bactéries › Proteobacteria › Gammaproteobacteria › Enterobacteriaceae › Escherichia › Escherichia coli › Oxacillinase-484-Producing Enterobacterales,...
questionsmedicales.fr › Sciences humaines › Histoire › Histoire moderne 1601- › Histoire du 21ème siècle › Oxacillinase-484-Producing Enterobacterales,...